Search - tctmd.com

Displaying 1 - 20 of 124

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1174: Impact of balloon post-dilation on long-term bioprosthesis durability after transcatheter aortic valve replacement

Presenter: Antonin Trimaille

October 28, 2025

Presentation NY Valves 2025

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

Presenter: Suzanne J. Baron

June 26, 2025

Presentation NY Valves 2025

Mitral: Durability You Can Count On

Presenter: Bassem M. Chehab

June 26, 2025

Presentation NY Valves 2025

Two-Year Durability and Cardiac Remodeling After Transcatheter Mitral Chordal Repair (Neochord Nexus)

Presenter: Edwin Ho

June 26, 2025

Presentation NY Valves 2025

Can We Solve the Durability Issue? Insights Into New Valve Designs

Presenter: Tamim M. Nazif

June 25, 2025

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Presenter: Julien Ternacle

October 30, 2024

Presentation TCT 2024

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Presenter: Philippe Pibarot

October 30, 2024

Presentation TCT 2024

Lessons Learned From the SMART Trial

Presenter: Howard Herrmann

October 30, 2024

Presentation TCT 2024

TCT 638: Impact of Acute Hemodynamic Effects on Myocardial Remodeling and Mid-Term Durability After Transcatheter Edge-to-Edge Repair (TEER) of Mitral Regurgitation Using PASCAL®

Presenter: Tobias Geisler

October 28, 2024

Presentation TCT 2024

TCT 949: Long-term Mechanical Durability of Surgical Aortic Valves: A 2 Billion Cycle In Vitro Study

Presenter: Jae Hyun Jae

October 28, 2024

Presentation NY Valves 2024

TAVR Durability: What Do We Know So Far?

Presenter: Helene Eltchaninoff

June 07, 2024

Presentation NY Valves 2024

Importance of Valve Durability and Avoiding Patient-Prosthesis Mismatch

Presenter: Samir R. Kapadia

June 06, 2024

Presentation NY Valves 2024

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

Presenter: Philippe Pibarot

June 06, 2024

Presentation NY Valves 2024

You are Both Wrong, Engineers Hold the Key to Our Future and the Best Valve Design is Yet to be Found

Presenter: Ajit P. Yoganathan

June 06, 2024

Presentation NY Valves 2024

SAVR Will Have a Longer Lasting Durability Than TAVR

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

TAVR Will Have a Longer Lasting Durability Than SAVR

Presenter: Michael J. Reardon

June 06, 2024

Presentation NY Valves 2024

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Presenter: Mark Lebehn

June 06, 2024

Presentation NY Valves 2024

Cases 1/2 : TAVR at 8 Years and SVD at 2 Years

Presenter: Guillaume Bonnet

June 06, 2024

Presentation NY Valves 2024

Subclinical Leaflet Thrombosis : Identification, Incidence and Importance

Presenter: Raj Makkar

June 06, 2024

Advertisement

TCT 1174: Impact of balloon post-dilation on long-term bioprosthesis durability after transcatheter aortic valve replacement

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

Mitral: Durability You Can Count On

Two-Year Durability and Cardiac Remodeling After Transcatheter Mitral Chordal Repair (Neochord Nexus)

Can We Solve the Durability Issue? Insights Into New Valve Designs

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Lessons Learned From the SMART Trial

TCT 638: Impact of Acute Hemodynamic Effects on Myocardial Remodeling and Mid-Term Durability After Transcatheter Edge-to-Edge Repair (TEER) of Mitral Regurgitation Using PASCAL®

TCT 949: Long-term Mechanical Durability of Surgical Aortic Valves: A 2 Billion Cycle In Vitro Study

TAVR Durability: What Do We Know So Far?

Importance of Valve Durability and Avoiding Patient-Prosthesis Mismatch

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

You are Both Wrong, Engineers Hold the Key to Our Future and the Best Valve Design is Yet to be Found

SAVR Will Have a Longer Lasting Durability Than TAVR

TAVR Will Have a Longer Lasting Durability Than SAVR

Cases 3/4 : SAVR at 10 Years and SVD at 2 Years: Echo and Clinical

Cases 1/2 : TAVR at 8 Years and SVD at 2 Years

Subclinical Leaflet Thrombosis : Identification, Incidence and Importance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content